Reflection and recommendation as EU and US scrutinise foreign trial data
This article was originally published in SRA
Executive Summary
The integrity of clinical trial data is never far from the spotlight these days, with companies and regulators coming under increasing pressure to be more transparent in how they report and publish trial results.